Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Dengue fever is the most rapidly spreading mosquito-borne disease and has grown to be a major public health issue, especially in tropical nations like Bangladesh. Globally, children, adolescents, and young adults bear the largest burden of Dengue; the infection rate is highest among infants. However, the epidemiology of pediatric dengue virus infection has been poorly explored in Bangladesh.

Materials And Methods: This study was carried out at the Bangladesh Shishu Hospital & Institute from July to October 2023. Among 1102 admitted patients, 722 who were positive for dengue rapid test were enrolled.

Results: The highest number of positive patients were 1-5 years old (38 %) followed by 5-10 years (32 %). Vomiting (49 %) was most common after fever (100 %). 71 % of patients showed warning signs, with 17 deaths. All patients received antibiotics, and the number of different antibiotics increased with hospital stay. Real-time RT-PCR was conducted on purposively selected 104 rapid test positives and 50 negatives for serotyping. DENV-2 was the most predominant serotype (80 %), followed by DENV-3 (20 %).

Conclusion: This study underscored the need for targeted public health interventions, especially for children with warning signs, to address the high burden of pediatric dengue infection in Bangladesh.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jiph.2025.102684DOI Listing

Publication Analysis

Top Keywords

pediatric dengue
12
epidemiology pediatric
8
dengue virus
8
virus infection
8
public health
8
dengue infection
8
rapid test
8
warning signs
8
dengue
6
infection
4

Similar Publications

Hepatitis A virus (HAV) typically causes a self-limiting illness in children. Rarely, it can progress to fulminant hepatic failure (FHF), and even less commonly, may be followed by features suggestive of autoimmune hepatitis (AIH). The diagnostic overlap can be particularly challenging in tropical regions, where endemic infections such as dengue and malaria may present with similar clinical features.

View Article and Find Full Text PDF

The therapeutic value of antiviral nucleoside analogs was highlighted during the coronavirus disease 2019 (COVID-19) pandemic, with remdesivir and molnupiravir repurposed for their broad-spectrum antiviral activity. The cytidine analog azvudine (FNC) has recently gained attention as a potential treatment for human immunodeficiency virus type 1 (HIV-1) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Considering the distinct substrate specificities of HIV-1 reverse transcriptase (RT) and SARS-CoV-2 RNA-dependent RNA polymerase (RdRp), a unifying mechanism of inhibition remains elusive.

View Article and Find Full Text PDF

Background: There are currently no specific guidelines for neonatal dengue. The available guidelines focus on the pediatric age group. The objective of this study is to summarize the clinical presentations and management strategies, based on the available studies in literature and to report another case of neonatal dengue.

View Article and Find Full Text PDF

Recent Advances in Vaccine Development for Flaviviruses and Alphaviruses.

Vaccines (Basel)

July 2025

Instituto Politécnico Nacional (IPN), Av. Luis Enrique Erro s/n. Unidad Adolfo López Mateos, Mexico City 07738, Mexico.

Mosquito-borne viruses such as dengue (DENV), yellow fever (YFV), Zika (ZIKV), and chikungunya (CHIKV) have re-emerged in recent decades, affecting millions of people worldwide [...

View Article and Find Full Text PDF

Recapitulating dengue virus infection with human pluripotent stem cell-derived liver organoids for antiviral screening.

Nat Commun

August 2025

State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, China.

Dengue virus (DENV) poses a major global health threat, affecting an estimated 100 to 400 million people annually. The infection and pathogenesis remain incompletely understood, and no antiviral drug is currently approved for DENV treatment. Here, we develop a human pluripotent stem cell (hPSC)-derived liver organoid (hPLO) model to characterize DENV infection and screen for antivirals.

View Article and Find Full Text PDF